Who doesn't want cancer testing results at lower cost, with greater speed and accuracy? Interdisciplinary innovators like ...

Enrollment continues in EMBRACE, the second pivotal study of the Phase 3 PARADIGM ProgramParticipant rollover is ongoing into the EXTEND ...

Romania’s interim foreign minister, Oana Țoiu, announced on Monday, July 20, that the Visa Waiver program remains a priority ...

N-Zyme Biomedical today announced the successful closing of its Series A financing, raising approximately US$4.6 million to accelerate the advancement of its Phase 2 clinical programs and further the ...

Traditionally, treatments focused on boosting serotonin levels or other neurotransmitters, resulting in long waiting periods for patients to notice any changes, without any assurance of effectiveness.

Samsung Electronics and SK hynix have launched parallel campaigns to recruit doctoral-level semiconductor talent, following ...

Eli Lilly's acquisition of psychedelic drug maker AtaiBeckley extends Big Pharma's embrace of a stigmatized class of ...

Depression remains one of the most stubborn problems in modern medicine, and the numbers behind it are staggering. Tens of millions of adults live with major depressive disorder, and the majority ...

The NHL franchise is taking control of its local broadcasts, ditching traditional regional networks to deliver innovative ...

The Jazz at the Beach concert series rolled on Tuesday night.

FLYTEK launched GuideX on Friday, an intelligent interaction agent for public service environments, at the World Artificial ...

CodeeBot, a pioneer in educational technology, today announced the official launch of CodeeBot-a groundbreaking, screen-free tangible coding platform designed to make programming logic intuitive, ...